Cargando…
Primary prophylaxis with biosimilar filgrastim cost-effective approach to avoid febrile neutropenia
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049858/ https://www.ncbi.nlm.nih.gov/pubmed/33880006 http://dx.doi.org/10.1007/s40274-021-7640-0 |
_version_ | 1783679499078991872 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8049858 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-80498582021-04-16 Primary prophylaxis with biosimilar filgrastim cost-effective approach to avoid febrile neutropenia PharmacoEcon Outcomes News Clinical Study Springer International Publishing 2021-04-17 2021 /pmc/articles/PMC8049858/ /pubmed/33880006 http://dx.doi.org/10.1007/s40274-021-7640-0 Text en © Springer International Publishing AG 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Clinical Study Primary prophylaxis with biosimilar filgrastim cost-effective approach to avoid febrile neutropenia |
title | Primary prophylaxis with biosimilar filgrastim cost-effective approach to avoid febrile neutropenia |
title_full | Primary prophylaxis with biosimilar filgrastim cost-effective approach to avoid febrile neutropenia |
title_fullStr | Primary prophylaxis with biosimilar filgrastim cost-effective approach to avoid febrile neutropenia |
title_full_unstemmed | Primary prophylaxis with biosimilar filgrastim cost-effective approach to avoid febrile neutropenia |
title_short | Primary prophylaxis with biosimilar filgrastim cost-effective approach to avoid febrile neutropenia |
title_sort | primary prophylaxis with biosimilar filgrastim cost-effective approach to avoid febrile neutropenia |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049858/ https://www.ncbi.nlm.nih.gov/pubmed/33880006 http://dx.doi.org/10.1007/s40274-021-7640-0 |